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T
he randomized controlled trial (RCT) 
is the ideal study design to address 
intervention questions.1 In an RCT, 
patients are allocated to an interven-
tion or control group on the basis of chance. 
The strengths of this methodology include that 
it minimizes confounding by producing groups 
that are comparable in terms of baseline char-
acteristics. In theory, this provides comparable 
prognoses of the groups prior to intervention. 
The reliability of an individual RCT, however, 
is affected by the methodological aspects of 
randomization procedures, which are reflected 
by the completeness and quality of reporting. 
When reporting is inadequate or superficial, 
confidence in the credibility of study proce-
dures and results is diminished.
There are certain attributes that define the 
quality of the procedures and reporting of RCTs. 
The Consolidated Standards of Reporting Trials 
(CONSORT) Statement, a widely accepted set 
of standards for reporting of clinical trials, lists 
four minimum requirements for reporting of 
randomization methodology.2 The first is a clear 
explanation of the method by which the ran-
dom sequence is generated. Second is an expla-
nation of the type of randomization as simple 
ran domization, permuted block (to avoid 
imbalances in allocation), stratification (to 
balance the distribution of certain baseline risk 
factors), or a combination of these techniques. 
Third is allocation concealment, the method of 
preventing study personnel from having aware-
ness of treatment assignment before enrolling 
patients. Finally, there needs to be full reporting 
on the methods of implementation of randomi-
zation procedures.2 It is well worth noting that 
the CONSORT Statement goes well beyond 
reporting on randomization, and other aspects 
are highly valuable.2
Clinicians, guideline groups, and policy 
makers rely on the results of RCTs. It is clear, 
therefore, that the quality of design, conduct, 
and reporting of RCTs is a fundamental step in 
determining valid and applicable results. Stud-
ies with suboptimal quality may be misleading 
as to the true effects of interventions. The ability 
to advance clinical care may hence be hindered, 
while both resources and the volunteerism of 
study subjects may be squandered. High-qual-
ity reporting of methodology increases the 
credibility, applicability, and generalizability 
of methods and results. It should be noted that 
nephrology publishes the fewest RCTs of any 
medical specialty.3 When the number of RCTs 
in a field is less, then the contribution of each 
individual study to the accumulated literature 
and knowledge base is proportionately greater. 
As a result there is an even heightened burden 
of responsibility for high-quality reporting. The 
purpose of this Editorial is to discuss quality 
of randomization reporting in clinical trials in 
nephrology.
We reviewed nephrology RCTs published in 
13 nephrology and four general medical jour-
nals between 1 July 2010 and 30 June 2011 (see 
Supplementary Methods and Supplementary 
Figure S1 online) to explore these domains. A 
total of 74 articles met the inclusion criteria, 
and their characteristics are reported in Table 
1. Sixty of 74 (82%) were published in nephrol-
ogy journals, and 52 of 74 (70%) had sample 
sizes of fewer than 200 patients.
The four CONSORT indicators of the quality 
of randomization could be ascertained from all 
articles. The method of sequence generation was 
not reported in 44 of 74 studies (59.5%) (Table 
2). Randomization type was not reported in 29 
of 74 publications (39.2%). When the type was 
reported, some form of stratification, permuted 
block, or a combination was used in 48.6% of 
studies (permuted block alone in 12.2%, strati-
fication alone in 20.3%). Most studies that did 
not report randomization type used simple ran-
domization, on the basis of responses provided 
by the authors of 16 studies. The method of allo-
cation concealment was not reported in 43 of 74 
studies (58.1%); when it was reported, central 
allocation was the most common procedure. 
Finally, in the vast majority of cases, informa-
tion was not provided on how and by whom 
randomization was implemented.
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Only 5 of 74 studies (6.8%) reported suf-
ficiently on all four items identified in the 
CONSORT Statement. Importantly, 19 of 74 
articles (25.7%) provided no information at all 
on randomization methodology. For what are 
arguably the two most critical aspects of ran-
domization reporting, randomization type and 
method of allocation concealment, only 24 of 
74 studies (32.4%) reported acceptably. We 
analyzed these 24 publications to explore how 
they differed from other published studies and 
which were the factors predictive of acceptable 
reporting. Single-center studies were less likely 
than multicenter studies to report adequately 
on the key components (15.2% versus 46.3%, P 
= 0.006), and studies with binary and time-to-
event primary end points were more likely than 
studies that used continuous primary end points 
(55.6% versus 19.1%, P = 0.002). It should be 
noted that these are associations and not neces-
sarily inherent causes of reporting deficiencies.
There was a larger effect size for the primary 
end point in studies with inadequate reporting of 
randomization; studies with acceptable report-
ing found smaller effect sizes (0.16 ± 0.09 versus 
0.34 ± 0.16, P < 0.001). This is confirmatory of 
the possibility raised by others that as methodo-
logical quality falls, reported intervention effect 
size increases.4
Taken together, our findings indicate that 
reporting of randomization methodology is sub-
optimal in most nephrology trial publications. 
Because our analysis was not comprehensive, 
but limited to major and second-line journals, 
a degree of selection bias may possibly be a 
limitation. Previously, it has been reported that 
nephrol ogy lags behind all other medical special-
ties in the number of published RCTs.3 Although 
the number increased between 1966 and 2010, 
nephrology still publishes the fewest RCTs.5 It is 
worth noting that the problem of low quality of 
reporting on randomization procedures has been 
found in other specialties as well.6,7
Clear and thorough reporting is essential 
for understanding the rigor of randomization 
processes. A failure to report on key aspects 
of randomization methodology diminishes 
the credibility of reported results, and this is 
particularly important in disciplines such as 
nephrology, where there are few randomized 
trials to reliably inform practice. Accordingly, 
the CONSORT Statement places particular 
emphasis on reporting requirements related 
to randomization in publications.2 Adequate 
description of the method used to gener-
ate the random allocation sequence makes it 
possible to assess the likelihood of bias in the 
process. The type of randomization needs to be 
described so that the reader can assess whether 
any restrictions were in place, and how they 
were employed. It is acceptable to state, “The 
method of patient allocation was simple rand-
omization,” if this was the method. In contrast, if 
block randomization was used, then the method 
for block generation and block size should be 
specified. For stratification, which variables were 
involved and cutoff values within strata should 
be delineated. The method of allocation con-
cealment should be clearly explained to assure 
that investigators were blinded to new patients’ 
treatment assignment. Acceptable methods are 
allocation by a central source, use of a pharmacy 
independent of study-blinded personnel, and 
use of sequentially numbered opaque sealed 
envelopes. Finally, the methods of randomiza-
tion implementation help the reader understand 
who generated the randomization sequence, 
enrolled participants, and assigned patients to 
interventions. Altogether, rigorous reporting 
creates confidence in the credibility of study 
procedures and results. However, as important 
as reporting quality is, the design and execution 
Table 1 | Characteristics of randomized 
controlled trials analyzed
 n (%)
Number of articles 74
Journal type:  
Nephrology 60 (81.1)
General medicine 14 (18.9)
Patient type:  
Chronic kidney disease 34 (45.9)
Dialysis 26 (35.1)
Transplantation 14 (18.9)
Sample size:  
0–200 52 (70.3)
>200 22 (29.7)
Multicenter study  
Yes 41 (55.4)
No 33 (44.6)
Primary outcome type:
Continuous 47 (63.5)
Binary 21 (28.4)
Time to event 6 (8.1)
Funding source:
Industry 34 (45.9)
Governmental 20 (27.0)
Other 17 (23)
Not reported 3 (4.1)
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of the randomization process are vitally impor-
tant as well. It is not always possible from the 
published article to ascertain these characteris-
tics of a study.
In conclusion, we found that reporting of ran-
domization methodology was insufficient in the 
majority of published nephrology RCTs. Because 
of the effort and resources devoted to RCTs, it is 
important that the results can be relied upon. 
When reporting is insufficient, the applicabil-
ity and reliability of results are weaker, and the 
evidentiary value of the results is diminished. 
We recommend that investigators in nephrol-
ogy design RCTs and report results following the 
CONSORT Statement criteria, and that editors 
of journals pay particular attention to adequate 
reporting of the randomization processes.
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Table 2 | Randomization characteristics
n (%)
Sequence generation:
None reported 44 (59.5)
Computer 26 (35.1)
Table 3 (4.1)
Other 1 (1.3)
Randomization type:  
None reported 29 (39.2)
Simple 9 (12.2)
Stratified 16 (21.6)
Permuted block 8 (10.8)
Block and stratified 12 (16.2)
Allocation concealment:  
None reported 43 (58.1)
Central 19 (25.7)
Pharmacy 4 (5.4)
Sequentially numbered opaque 
sealed envelopes 8 (10.8)
Randomization implementation:  
Not reported 64 (86.5)
Yes 10 (13.5)
